These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 29170909)
1. New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model. Louis N; Liu S; He X; Drummond DC; Noble CO; Goldman S; Mueller S; Bankiewicz K; Gupta N; Hashizume R J Neurooncol; 2018 Feb; 136(3):475-484. PubMed ID: 29170909 [TBL] [Abstract][Full Text] [Related]
2. Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy. Noble CO; Krauze MT; Drummond DC; Yamashita Y; Saito R; Berger MS; Kirpotin DB; Bankiewicz KS; Park JW Cancer Res; 2006 Mar; 66(5):2801-6. PubMed ID: 16510602 [TBL] [Abstract][Full Text] [Related]
3. Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals. Wang W; Sivakumar W; Torres S; Jhaveri N; Vaikari VP; Gong A; Howard A; Golden EB; Louie SG; Schönthal AH; Hofman FM; Chen TC Neurosurg Focus; 2015 Mar; 38(3):E8. PubMed ID: 25727230 [TBL] [Abstract][Full Text] [Related]
4. Convection-Enhanced Delivery of Enhancer of Zeste Homolog-2 (EZH2) Inhibitor for the Treatment of Diffuse Intrinsic Pontine Glioma. Sasaki T; Katagi H; Goldman S; Becher OJ; Hashizume R Neurosurgery; 2020 Nov; 87(6):E680-E688. PubMed ID: 32674144 [TBL] [Abstract][Full Text] [Related]
5. Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma. Sasaki T; Watanabe J; He X; Katagi H; Suri A; Ishi Y; Abe K; Natsumeda M; Frey WH; Zhang P; Hashizume R J Neurosurg; 2023 Jun; 138(6):1570-1579. PubMed ID: 36599085 [TBL] [Abstract][Full Text] [Related]
6. Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenografts. Chen PY; Ozawa T; Drummond DC; Kalra A; Fitzgerald JB; Kirpotin DB; Wei KC; Butowski N; Prados MD; Berger MS; Forsayeth JR; Bankiewicz K; James CD Neuro Oncol; 2013 Feb; 15(2):189-97. PubMed ID: 23262509 [TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma. Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, tumor accumulation and antitumor activity of nanoliposomal irinotecan following systemic treatment of intracranial tumors. Noble CO; Krauze MT; Drummond DC; Forsayeth J; Hayes ME; Beyer J; Hadaczek P; Berger MS; Kirpotin DB; Bankiewicz KS; Park JW Nanomedicine (Lond); 2014 Jul; 9(14):2099-108. PubMed ID: 24494810 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of vincristine administered via convection-enhanced delivery in a rodent brainstem tumor model documented by bioluminescence imaging. Xi G; Rajaram V; Mania-Farnell B; Mayanil CS; Soares MB; Tomita T; Goldman S Childs Nerv Syst; 2012 Apr; 28(4):565-74. PubMed ID: 22282078 [TBL] [Abstract][Full Text] [Related]
15. Combination Therapy of Intraperitoneal Rapamycin and Convection- Enhanced Delivery of Nanoliposomal CPT-11 in Rodent Orthotopic Brain Tumor Xenografts. Mendiburu-Eliçabe M; Gil-Ranedo J Curr Cancer Drug Targets; 2015; 15(4):352-62. PubMed ID: 25714699 [TBL] [Abstract][Full Text] [Related]
17. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children. Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851 [TBL] [Abstract][Full Text] [Related]
18. Convection-enhanced delivery of a synthetic retinoid Am80, loaded into polymeric micelles, prolongs the survival of rats bearing intracranial glioblastoma xenografts. Yokosawa M; Sonoda Y; Sugiyama S; Saito R; Yamashita Y; Nishihara M; Satoh T; Kumabe T; Yokoyama M; Tominaga T Tohoku J Exp Med; 2010 Aug; 221(4):257-64. PubMed ID: 20622491 [TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier disruption and delivery of irinotecan in a rat model using a clinical transcranial MRI-guided focused ultrasound system. McDannold N; Zhang Y; Supko JG; Power C; Sun T; Vykhodtseva N; Golby AJ; Reardon DA Sci Rep; 2020 May; 10(1):8766. PubMed ID: 32472017 [TBL] [Abstract][Full Text] [Related]
20. The influence of trapping agents on the antitumor efficacy of irinotecan liposomes: head-to-head comparison of ammonium sulfate, sulfobutylether-β-cyclodextrin and sucrose octasulfate. Yang W; Yang Z; Fu J; Guo M; Sun B; Wei W; Liu D; Liu H Biomater Sci; 2018 Dec; 7(1):419-428. PubMed ID: 30500018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]